JIA Oligoarthritis, TMJ, and sJIA 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
Documents related to the 2021 JIA oligoarthritis, TMJ, and sJIA guideline:
JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging
Documents related to the 2021 JIA nonpharmacologic, medication monitoring, immunizations, and imaging guideline:
JIA American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis - 2019
Documents related to the 2019 JIA guideline:
JIA Uveitis American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis - 2019
Documents related to the 2019 JIA uveitis guideline:
2013 Update of 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis
Documents related to the 2013 JIA guideline:
American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis - 2011
Clinician Guide - 2011